ABSTRACT The microbiota of the mammalian gastrointestinal tract is a complex ecosystem of bacterial communities that continuously interact with the mucosal immune system. In a healthy host, the mucosal immune system maintains homeostasis in the intestine and prevents invasion of pathogenic bacteria, a phenomenon termed colonization resistance. Antibiotics create dysbiosis of microbiota, thereby decreasing colonization resistance and facilitating infections caused by antibiotic-resistant bacteria. Here we describe how cephalosporin antibiotics create dysbiosis in the mouse large intestine, allowing intestinal outgrowth of antimicrobial-resistant Enterococcus faecium. This is accompanied by a reduction of the mucus-associated gut microbiota layer, colon wall, and Muc-2 mucus layer. E. faecium agglutinates intraluminally in an extracellular matrix consisting of secretory IgA (sIgA), polymeric immunoglobulin receptor (pIgR), and epithelial cadherin (E-cadherin) proteins, thereby maintaining spatial segregation of E. faecium from the intestinal wall. Addition of recombinant E-cadherin and pIgR proteins or purified IgA to enterococci in vitro mimics agglutination of E. faecium in vivo. Also, the Ca 2؉ levels temporarily increased by 75% in feces of antibiotic-treated mice, which led to deformation of E-cadherin adherens junctions between colonic intestinal epithelial cells and release of E-cadherin as an extracellular matrix entrapping E. faecium. These findings indicate that during antibiotic-induced dysbiosis, the intestinal epithelium stays separated from an invading pathogen through an extracellular matrix in which sIgA, pIgR, and E-cadherin are colocalized. Future mucosal vaccination strategies to control E. faecium or other opportunistic pathogens may prevent multidrug-resistant infections, hospital transmission, and outbreaks.
void of microbes (17, 18) . Mucus forms a separation barrier, and IgA ϩ plasma cells produce sIgA in the lamina propria and have an essential role in separating microbiota from the host by immune exclusion, by limiting adhesion to and invasion of the epithelium by microbiota by coating bacterial surfaces and agglutinating bacterial cells (7, (19) (20) (21) . sIgA binds to the polymeric immunoglobulin receptor (pIgR), a glycoprotein expressed basolaterally on polarized secretory IECs (22) (23) (24) . sIgA complexes (pIgR-sIgA-J chain), as well as unoccupied pIgR, are internalized into the IEC and transported to the apical surface, where the extracellular part of pIgR is cleaved, leading to release of sIgA and unbound pIgR into the lumen (25) (26) (27) . Free pIgR has innate immune functions similar to those of sIgA, and bound to IgA, it protects sIgA from proteolytic degradation by microbial proteases in the lumen (28) . Perturbation of the intestinal microbiota can deregulate intestinal homeostasis, decrease colonization resistance, and facilitate outgrowth of antibiotic-resistant pathogens (1) . Multidrug-resistant Enterococcus faecium has emerged as an important cause of hospital-acquired infections in debilitated patients and can become the dominant intestinal species when hospitalized patients receive antibiotics (29) (30) (31) . Antibiotics diminish intestinal Gramnegative bacteria and result in downregulated expression of the antimicrobial peptide Reg3␥, facilitating outgrowth of E. faecium (32) . Consequently, the intestines of these patients represent a reservoir from which E. faecium can spread and potentially cause infections of the urinary tract, bloodstream, and surgical sites (29) . Antibiotic treatment can also alter intestinal pathology (33) (34) (35) . For instance, metronidazole altered the microbiota and goblet cell function, leading to a reduction of mucin-2 expression and reduction of the protective mucus layer (36) . An altered microbiota, accompanied by decreased levels of Reg3␥, and a thinned mucus layer, reduces the defensive barrier and immune homeostasis. We therefore investigated the intestinal architecture of mice during antibiotic-induced perturbation of the microbiota and subsequent outgrowth of two resistant E. faecium isolates in two different animal experiments. We showed that intestinal dysbiosis was accompanied by a reduced mucus separation barrier and enhanced intraluminal agglutination of E. faecium in a matrix consisting of sIgA, pIgR, and E-cadherin. We hypothesize that this matrix contributes to the segregation of E. faecium from the intestinal epithelium when the mucus layer is reduced.
RESULTS

Antibiotics cause dysbiotic outgrowth of resistant E. faecium.
To mimic dysbiotic outgrowth of a multiresistant opportunistic pathogen, we treated mice with antibiotics and orally administered antibiotic-resistant E. faecium strain E980 (four mice per group) or E1162 (four mice per group) and inoculated untreated animals with E980 or E1162 (four mice per group; thus, eight mice). Control groups were either left untreated (0.9% NaCl; three mice) or treated with antibiotics only (three mice). This experiment was repeated with an additional two mice per group to increase the total number of mice per group and confirm the imaging results (see below) (Fig. 1a) . In the groups receiving antibiotics (eight mice), strain E1162 reached~10 ϫ 10 10 bacteria/g of feces and strain E980 reached~5 ϫ 10 5 bacteria/g of feces on day 1, and both isolates stably colonized the mouse gut at~10 ϫ 10 10 bacteria/g of feces from day 3 until day 10 (Fig. 1b) . Strain E980 or E1162 also stably colonized the guts of untreated mice for 10 days, albeit at lower levels (~1 ϫ 10 5 bacteria/g of feces) than antibiotic-treated mice. No E. faecium was cultured from either control group. Enumeration of CFU from homogenates of the duodenum, jejunum, ileum, cecum, and colon detected colonization by enterococci of the small intestines (10 3 to 10 4 CFU/g of tissue) and in the ceca and colons (10 5 CFU/g of tissue) of animals not receiving antibiotics (Fig. 1c) . The level of colonization was 100ϫ to 10,000ϫ higher in the small intestines (10 5 to 10 8 CFU/g of tissue), ceca, and colons (10 10 CFU/g of tissue) of antibiotictreated animals. To confirm Enterococcus-specific outgrowth, bacterial diversity was determined on the basis of 16S rRNA gene profiling from feces from day Ϫ2 until day 10 (Fig. 1d) . On day Ϫ2, the microbial composition was similar in all groups. The eight major taxa in these groups were Clostridiales (2.2 to 25.8% of all sequences), Lactobacillaceae (0.7 to 62.4%), Bacteroidales (15.9 to 78.7%), Prevotellaceae (0.2 to 9.8%), Ruminococcaceae (0.4 to 7.3%), Desulfovibrionaceae (0.1 to 7.7%), Bacteroidaceae (0.2 to 7.2%), and Coriobacteriaceae (0.9 to 17.9%). The composition remained stable in the untreated control mice from day Ϫ2 until day 10. Animals administered antibiotics only and not receiving E. faecium had a greatly diminished microbiota. In contrast, in animals treated with antibiotics and inoculated with E. faecium E980 or E1162, the microbiota was dominated by Enterococcus bacteria (59.2 to 99.8% and 97.2 to 99.9%, respectively) from day 1 until day 10, indicating that cephalosporin antibiotics led to dysbiotic proliferation of E. faecium in the large intestine. Alignment of fecal 16S rRNA gene sequences to E. faecium 16S rRNA gene sequences demonstrated that E. faecium was the dominant species from day 1 until day 10 (see Fig. S1 in the supplemental material) and that the Enterococcaceae family bacteria detected on day 0 in mice that received antibiotics and E980 or E1162 were E. gallinarum. This was confirmed by a specific PCR reaction of the E. faecium ddl housekeeping gene of DNA extracted from fecal samples.
Antibiotics drive alteration of intestinal architecture in mice. Detailed visualization of the changes in intestinal architecture was performed by Gram staining of Carnoy's solution-fixed and formalin-fixed colon tissue of animals sacrificed on days 1 and 10 from two independent animal experiments. This revealed similar results on both days 1 and 10. Thick layers of microbiota were observed on the apical side of the epithelium of untreated mice (n ϭ 4; 99.7 to 115 m, days 1 and 10) and untreated mice inoculated with either E980 (n ϭ 2; 105 m) or E1162 (n ϭ 4; 104.8 to 161 m) on days 1 and 10 ( Fig. 2a and b ; see Fig. S2 in the supplemental material). Interestingly, this layer was larger in untreated animals inoculated with E1162 than in untreated animals. The microbiota layer was reduced significantly (133ϫ) in animals treated with antibiotics (n ϭ 4; 0.89 m; P ϭ 0.0001) and in animals treated with antibiotics and inoculated with E980 (n ϭ 2; 32 m) or E1162 (n ϭ 4;~1 to 40 m; P ϭ 0.0001) (Fig. 2b ) compared to that of untreated animals. Also, the colon wall comprising the crypts of Lieberkühn with underlying tissue was reduced to 122 m (day 1) and 81 m (day 10) in antibiotic-treated animals and antibiotic-treated animals inoculated with E980 (94 m) or E1162 (105 to 92 m; P ϭ 0.0001, respectively), compared to that of untreated animals (146 to 143 m, days 1 and 10) or untreated mice inoculated with E980 (160 m; P ϭ 0.01) or E1162 (146 to 122 m; not significant and P ϭ 0.001, respectively) (Fig. 2c) .
In untreated animals, the mucus layer was, on average, 56 m (day 1) and 54 m (day 10) and distinguishable ( Fig. 2d and e ; see (Fig. 2e) . Analysis of colon thin sections by immunofluorescence (IF) assay with specific anti-Mucin-2 antibodies revealed a Mucin-2 layer in untreated animals, but the absence of Mucin-2 on the apical side of the epithelium in antibiotic-treated mice on day 1 ( Fig. 2e ) and day 10 (see Fig. S3 ). Complementary, Western blotting of fecal extracts obtained during the course of the experiment with specific anti-Mucin-2 antibodies revealed that Mucin-2 was present only in untreated animals and in all of the animals on day Ϫ2 (Fig. 2f) . Taken together, these results indicate that antibiotic treatment greatly affects the architecture of the host's main barrier against the intestinal microbiota.
An extracellular matrix separates E. faecium from IECs in the antibiotic-treated host. To assess whether E. faecium E980 or E1162 directly interacts with the intestinal epithelium in antibiotic-treated animals, we analyzed whole cecum and colon tissue by scanning electron microscopy (SEM) and Gram-stained thin sections by light microscopy. SEM revealed that in antibiotictreated mice diplococci were embedded in an extracellular matrix in the cecum and colon and did not directly interact with IECs ( Fig. 3a) . In contrast, in cecum and colon tissue sections from untreated animals and animals inoculated with either E980 or E1162, this extracellular matrix could not be detected; instead, a rod-shaped microbiota on the apical side of the epithelium was revealed (Fig. 3b) . In control animals treated with only antibiotics, this extracellular matrix, in which occasionally a bacterial cell was entrapped, was also visible by SEM (Fig. 3b) . Thin-section light microscopy corroborated this finding and showed that in animals treated with antibiotics and inoculated with E980 or E1162, Gram-positive (purple) cocci were detected in a thin layer on the apical side separated from the epithelium (see Fig. S4 in the supplemental material). In mice not treated with antibiotics, the microbiota was separated from the host epithelium by the intact mucus layer ( Fig. 2e and Fig. S3 ). However, in some instances, not enough DNA could be extracted or the sequencing run failed. In those cases, data based on fecal pellets of only two mice per time point are shown. This was the case for antibiotic-treated mice inoculated with E980 on days 1 and 10 and mice treated with the antibiotics only on days 0, 1, and 10. For mice treated with the antibiotics and inoculated with E. faecium E980, an additional time point, day 6, was analyzed to compensate for the missing day 1 and 10 data.
Antibiotics cause intestinal enterococcal agglutination by host determinants.
To analyze determinants that constitute this extracellular matrix that segregated E. faecium from IECs, we punctured the ceca of mice and used their contents in IF assays (Fig. 4) . Cocci could only be detected in large bacterial agglutinations in the ceca of animals treated with antibiotics and inoculated with E. faecium E980 or E1162 (Fig. 4a) and not in untreated control animals. In the latter, only rod-shaped bacteria were found (Fig. 4b) . It is known that IgA and pIgR are secreted at high levels within the intestines (37) . Therefore, we assessed whether sIgA and pIgR contribute to the agglutination of cocci in mice treated with antibiotics and inoculated with E. faecium E980 or E1162. IF analysis with specific anti-IgA and anti-pIgR antibodies demonstrated that IgA and pIgR were detected in the agglutinates and bound to the bacterial surface in antibiotic-treated animals that also received E980 or E1162 (Fig. 4a) and to a lesser extent to rod-shaped bacteria in untreated animals (Fig. 4c) . We subsequently tested whether the adherens junction molecule E-cadherin contributes to in vivo agglutination (13) . IF assay with anti-E-cadherin antibodies demonstrated that E-cadherin is detected in the agglutinations and binds to enterococcal surfaces. No E-cadherin signal was detected at the surface of bacteria harvested from mice inoculated with E980 or E1162 or from untreated mice (Fig. 4a to c) . Animals treated with antibiotics only were not analyzed, as their ceca yielded only undigested debris. The cecum contents of four different mice incubated with conjugate alone also did not yield any signal (Fig. 4d) . This suggests that E-cadherin is released in the intestinal lumen upon cephalosporin-induced dys- In panels b to d, each group was compared to the "untreated" control mouse group; ns, not significant; *, P Ͻ 0.05; **, P Ͻ0.001; ***, P Ͻ0.0001.
biosis. Accordingly, Western blotting of fecal extracts with E-cadherin antibodies showed immunoreactive E-cadherin species only in animals treated with antibiotics and not in untreated animals (Fig. 4e) . Furthermore, E-cadherin labeling of adherens junctions in colon thin sections demonstrated deformed junctions in antibiotic-treated animals and normal junctions in untreated animals (Fig. 4f) . To further investigate agglutination of E. faecium by host molecules, 20 l of cleared and filter-sterilized fecal extracts from mice sampled at day Ϫ2 (i.e., no antibiotics) and day 1 (i.e., after 2 days of ceftriaxone injections and 1 day of cefoxitin in their drinking water of animals inoculated with E1162) were inoculated with 1 ϫ 10 5 E1162 bacteria/ml. This led to agglutination of E1162 into large clumps in the day 1 fecal extract only (Fig. 4g) . IF assay of these agglutinates demonstrated the presence of sIgA, pIgR, and E-cadherin as important determinants of agglutination of E. faecium (Fig. 4h) . Lastly, 10 g of recombinant E-cadherin, pIgR, and purified IgA proteins all agglutinated E1162 in vitro, as determined by IF assay, while bovine serum albumin did not (Fig. 4i) . Taken together, these data show that determinants released by the host in the cecum and colon decorate the enterococcal surface, leading to intraluminal agglutination.
Enterococci are separated from the intestinal epithelium by host determinants.
To analyze the relative locations of sIgA, pIgR, and E-cadherin within the cecum and colon in vivo, we performed IF analyses of thin sections with specific anti-IgA, anti-pIgR, and anti-E-cadherin antibodies. In all of the mouse groups, IgA ϩ plasma cells were detected within the lamina propria, pIgR protein was detected on Paneth cells on the basolateral side of the crypts, and E-cadherin was detected in the adherens junctions between the cells. In antibiotic-treated animals inoculated with E1162, the E-cadherin junctions were deformed compared to those of untreated animals ( Fig. 5a and b) , with indications of E-cadherin shedding into the intestinal lumen. In the antibiotic-treated host inoculated with E1162, enterococci were separated from the IECs by a distinct layer consisting of the sIgA, pIgR, and E-cadherin proteins in the cecum and colon that was absent from untreated animals ( Fig. 5a and b) or untreated animals inoculated with E980 or E1162 (not shown). These observations corroborate the Western blotting data in which E-cadherin was detected only in fecal extracts from mice treated with antibiotics (Fig. 4e) . Close-ups showed that the sIgA, pIgR, and E-cadherin proteins were present in agglutinated E1162 clumps. This was identical in mice treated with antibiotics and inoculated with E. faecium E980 (data not shown). Animals that were treated with antibiotics but did not receive E. faecium showed a comparable lining of sIgA, pIgR, and E-cadherin physically separated from IECs, in particular in the colon and to a lesser extent in the cecum (Fig. 5c) . Thin sections incubated with conjugate did not show a signal (Fig. 5d) .
Increased Ca 2؉ levels trigger deformation of E-cadherin junctions and entrapment of E. faecium in an extracellular matrix in vitro. An elevated Ca 2ϩ concentration may trigger metalloprotease-mediated E-cadherin cleavage and release (38), as we have observed in the ceca and colons of mice treated with antibiotics. Therefore, we assessed the Ca 2ϩ , Mg 2ϩ , and K ϩ ion concentrations in fecal extracts for their relative abundance in the intestines of antibiotic-treated mice. This demonstrated that after 2 days of ceftriaxone injections of mice, the fecal Ca 2ϩ ion concentration significantly (P ϭ 0.007) increased from 20 mM on day Ϫ2 to 35.5 mM on day 0 and decreased to normal levels from day 1 until day 10 (Fig. 6a) . Also, fecal Mg 2ϩ and K ϩ ion concentrations increased from 16.6 to 58.4 mM (P ϭ 0.009) and from 31.2 to 54.5 mM (P ϭ 0.002), respectively, and stabilized again from day 1 to day 10. Untreated animals did not display this transient increase in fecal cation concentrations, as their Ca 2ϩ concentrations were stable at 20 mM, their Mg 2ϩ concentrations were stable at, on average, 25.2 mM, and their K ϩ concentrations decreased from 48 to 20 mM (P ϭ 0.03) (Fig. 6b) . Increased Ca 2ϩ concentrations might be a reflection of the altered intestinal pathophysiology, as observed in mice treated with antibiotics, involving enlargement of the cecum and diarrheic fecal contents (see Fig. S5 in the supplemental material). This suggests that cations may act as signaling molecules in the gut during antibiotic treatment and induce the formation of bacterium-host molecule agglutinates. Therefore, we analyzed E-cadherin cleavage and agglutination of E. faecium E1162 on monolayers of human colon HT-29 cells in the presence of different cation concentrations. By Western blotting of HT-29 cell extracts, we demonstrated that 5, 10, and 20 mM Ca 2ϩ concentrations led to cleavage of E-cadherin while the other cations did not (Fig. 6c) . To confirm this, an IF assay with specific anti-E-cadherin antibodies on HT-29 monolayers incubated with E1162 showed concentration-dependent deformation of the adherens junctions and E-cadherin disposition on the apical side of HT-29 cells (Fig. 6d) . Similarly, SEM of HT-29 monolayers incubated with E. faecium E1162 and increasing Ca 2ϩ concentrations showed the formation of an extracellular matrix in which E1162 was entrapped (Fig. 6e) , while MgCl 2 or KCl concentrations of up to 20 mM did not (Fig. 6f) . As a control, addition of either 10 mM CaCl 2 or E1162 alone to HT-29 monolayers demonstrated that calcium triggers the deformation of junctions, leading to the production of an extracellular matrix and not E. faecium E1162 (Fig. 6e and f) . This in vitro deformation of junctions and Ca 2ϩ -mediated production of an extracellular matrix were highly similar to those observed in vivo in the ceca and colons of mice treated with antibiotics (Fig. 3) . Lastly, increasing Ca 2ϩ concentrations correlated with increased recovery of E1162 from this extracellular matrix on HT-29 cells (P ϭ 0.001) (Fig. 6g) .
DISCUSSION
The mammalian intestine is densely populated by commensal bacteria, which have an essential role in metabolism and protection against invading pathogens. Antibiotic therapy is known to perturb the intestinal microbiota and to reduce colonization resistance, allowing intestinal overgrowth of multiresistant pathogens such as multiresistant Enterococcus faecalis (39, 40) , E. faecium (30) (31) (32) , and Clostridium difficile (35) . Here we show in a murine model of intestinal dysbiosis that the mucus-associated microbiota and mucus layer are diminished in mice treated with cephalosporin antibiotics and that E. faecium is agglutinated in an extracellular matrix consisting of the host molecules sIgA, pIgR, and E-cadherin. In this way, E. faecium, which is able to colonize the intestines of antibiotic-treated hosts at high densities, remains physically separated from the IECs.
We assessed the antibiotic-induced alterations in microbiota composition and E. faecium outgrowth by 16S rRNA gene sequencing from feces in a mouse colonization model. We showed that upon cephalosporin antibiotic treatment and oral inoculation, two different E. faecium strains, E980 and E1162, are able to proliferate in the gastrointestinal tract. This is in line with what is found in particular categories of hospitalized patients treated with antibiotics (30, 31) . Hospitalized patients densely colonized by multiresistant E. faecium in the gut generally do not suffer from intestinal inflammation, and enterococcal colonization typically occurs unnoticed, suggesting adequate mucosal immune responses. In our mouse model, antibiotic-induced perturbation of the microbiota not only provoked high-density intestinal outgrowth of E. faecium but also resulted in an altered intestinal architecture characterized by (i) a reduced mucus-associated microbiota layer, (ii) a decreased colon wall diameter, (iii) a diminished mucus layer and Mucin-2 protein production, and (iv) deformation of the E-cadherin adherens junctions. Despite this, we did not observe direct attachment of E. faecium cells to IECs or translocation of E. faecium into the lamina propria, as previously demonstrated for E. faecalis (41) . Instead, we detected agglutinates that entrapped E. faecium and separated the enterococci from the underlying epithelium. These agglutinations formed an extracellular matrix located on the apical side of the intestinal epithelium and consisted of not only entrapped enterococci but also the host molecules sIgA, pIgR, and E-cadherin. sIgA containing bound pIgR and free luminal pIgR are known to protect the host against pathogenic infections and contribute to maintenance of immune homeostasis within the intestine (37) . However, the abilities of sIgA and pIgR to create spatial separation and protect the host IECs from opportunistic pathogens colonizing at high density has not been attributed to their function yet. The finding of soluble luminal E-cadherin protein contributing to agglutination of E. faecium in the extracellular matrix is also a novel observation. So far, it has been shown that soluble E-cadherin can be detected in the blood or urine of patients affected by breast, gastric, or colorectal cancer, and this has been associated with metastatic disease and a worse prognosis (42, 43) . In line with the detection of soluble luminal E-cadherin is the observation that the adherens junctions in the colonic columnar epithelium were deformed in vivo. This suggests that luminal E-cadherin protein has innate immune functions like sIgA and pIgR in the colonic lumen (37) . Both sIgA and pIgR were also detected in colonic extracts of antibiotic-treated animals and at the surface of E980 and E1162 in vivo. Furthermore, inoculation of E. faecium into colonic fecal extracts of antibiotic-treated animals led to agglutination of enterococci by sIgA, pIgR, and E-cadherin, and the incubation of E. faecium with recombinant E-cadherin, sIgA, and pIgR also confirmed that these host molecules were able to agglutinate E. faecium while bovine serum albumin was not.
The altered architecture observed in the cecum and colon wall and at the microbiota-epithelium interface was accompanied by a transient increase in Ca 2ϩ , Mg 2ϩ , and K ϩ concentrations in the feces of antibiotic-treated animals but not in that of untreated controls. In vitro, only elevated Ca 2ϩ and not Mg 2ϩ or K ϩ leads to cleavage of E-cadherin, deformation of the E-cadherin adherens junctions, and capture of E. faecium E1162 in an E-cadherin matrix. This extracellular matrix was morphologically highly similar to the matrix observed in the ceca and colons of animals treated with antibiotics. Increased luminal Ca 2ϩ , Mg 2ϩ , and K ϩ concentrations were also found in the mice after 2 days of ceftriaxone injections but were not prolonged when antibiotic treatment was changed to cefoxitin added to the drinking water of mice and when the mice were inoculated with E. faecium. A temporary increase in fecal metabolites (e.g., bile salts, N-acetylated amino acids, dipeptides, inositol isomers and metabolites, gammaglutamyl amino acids) has been observed previously in mice treated with clindamycin and was attributed to the lack of uptake by the microbiota (44) . This is possibly also the explanation for the changes in intestinal cations, since we also observed additional intestinal pathophysiological changes in mice treated with antibiotics, such as an enlarged cecum and diarrhea.
We propose the following model that describes antibioticinduced outgrowth of an opportunistic pathogen like E. faecium in the cecum and colon of a mammalian host (see Fig. S6 in the supplemental material). Under healthy conditions, the ceca and colons of mammals contain a diverse microbiota. Bacteria reach the outer mucus layer, but the inner mucus layer is devoid of bacteria, allowing strict separation of microbiota and IECs, colonization resistance, and immune homeostasis. This balance is further promoted by immune exclusion through the production of sIgA and pIgR at mucosal surfaces. The IEC layer forms the barrier against potentially invading bacteria, partially maintained by E-cadherin-based adherens junctions. After antibiotic administration and acquisition of a multidrug-resistant opportunistic pathogen, the microbiota of the host gets severely perturbed, leading to proliferation of E. faecium in the cecum and colon and a reduction of the mucus-associated microbiota and mucus layer. Furthermore, elevated Ca 2ϩ concentrations, possibly resulting from perturbation of the microbiota and reduced Ca 2ϩ uptake, induce E-cadherin cleavage and release and subsequent deformation of adherens junctions. We hypothesize that, upon these pathophysiological intestinal changes, the host maintains homeostasis and separates E. faecium from the underlying epithelium by agglutinating the bacteria in a matrix consisting of sIgA, pIgR, and E-cadherin. This may explain why patients densely colonized with multiresistant E. faecium, like vancomycin-resistant enterococci, in general do not suffer from intestinal inflammation. Insights into the mechanisms employed by the host to counter outgrowth by E. faecium may provide clues for future mucosal vaccination strategies to eradicate resistant enterococci from the intestine.
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